Lonafarnib With and Without Ritonavir in HDV (LOWR-1)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

November 30, 2015

Conditions

Chronic Hepatitis D Infection

Interventions

DRUG

lonafarnib

antiviral farnesyl transferase inhibitor

DRUG

peginterferon alfa-2a

immunomodulator

DRUG

ritonavir

CYP 3A4 inhibitor, lonafarnib booster

Trial Locations (1)

Ankara University Medical School, Ankara